⚕️ABBV’s Volatility Storm Is Back—This Straddle Play Could Be Huuge!

If you’re looking for an edge in the options market, AbbVie (ABBV) just flashed a powerful signal—one that has historically led to big, fast moves.

Our Hedge Fund Straddle Scan has picked up six signals since August, and every single one has resulted in a significant price move.

With earnings around the corner and drug pipeline news always lurking, ABBV’s options are trading at a 16% discount to fair value—a setup too good to ignore.

Inside, we break down why now could be the perfect time to take advantage of this mispricing before the market catches on.